Advertisements



Biotechs With No Drugs in Trial Are Raising Millions in IPOs

Biotech IPOs are on track for a near-record year, with a crop of offerings that are younger, more highly valued—and some say riskier—than any in recent memory......»»

Category: smallbizSource: wsjOct 31st, 2018

War against the superbugs: Mass. biotechs step up to fight antibiotic resistance

In a world where superbugs are overpowering various antibiotic drugs, threatening millions of lives, Massachusetts biotechs are fighting hard to ensure the bugs don't become the industry's kryptonite......»»

Category: topSource: bizjournalsOct 25th, 2018

Pfizer to Raise Prices on 41 Drugs

Pfizer plans to resume its practice of raising drug prices early next year after bowing to pressure from President Trump over the summer when the company rolled back some increases......»»

Category: asiaSource: wsjNov 17th, 2018

Months After Trump Scolded Pfizer About Raising Drug Prices, It’s Raising Prices on 41 Drugs, Report Says

"They are merely taking advantage of the poor & others unable to defend themselves," the president tweeted. In July, Pfizer backtracked on its plans to r.....»»

Category: europeSource: fortuneNov 16th, 2018

Australia’s CSIRO, CommBank Complete ‘Smart Money’ Blockchain Trial

Australia's federal science agency CSIRO and CommBank have trialed a blockchain payments prototype they say could save "hundreds of millions" a year......»»

Category: forexSource: coindeskNov 13th, 2018

The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. With the earnin.....»»

Category: earningsSource: benzingaNov 4th, 2018

The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. read more.....»»

Category: blogSource: benzingaNov 4th, 2018

Five things you need to know today, and why you don"t want to win the Mega Millions

Good morning, Boston. Here are five things you need to know to help start your busy day. Harvard affirmative action trial, continued A former Harvard Crimson reporter who now writes for Politico, Josh Gerstein explores not only the current trial alle.....»»

Category: topSource: bizjournalsOct 22nd, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs

Biotech stocks are staging a rebound following the losses incurred in the week ended Oct. 12 amid catalysts that include the third-quarter earnings s.....»»

Category: earningsSource: benzingaOct 21st, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results, Large-Cap Pharma Earnings And IPOs

Biotech stocks.....»»

Category: blogSource: benzingaOct 21st, 2018

IPO News This Week: 5 Firms Seeking $1.7 Billion in New Capital

Five firms plan to complete IPOs in the coming week, raising a total of nearly $1.7 billion. The week's dominant offer comes from a Brazilian payment processing firm seeking to raise $1 billion......»»

Category: blogSource: 247wallstOct 21st, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs

Here are a few catalysts that can dictate the directional moves of biotech stocks in the upcoming week: read more.....»»

Category: blogSource: benzingaOct 14th, 2018

The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs

Here are a few catalysts that can dictate the directional moves of b.....»»

Category: earningsSource: benzingaOct 14th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results And IPOs

As we step into the final quarter of 2018, biotech stocks have recorded double-digit gains for the year-to-date period. Will the run up continue? Stay tuned to the following events of the upcoming week. read more.....»»

Category: blogSource: benzingaOct 8th, 2018

IPO News This Week: 6 Firms to Test the Market

Following a bumper crop of 12 IPOs last week, another 6 firms will be taking a run at a listing in the coming week. Two software makers and two biotechs are in the mix......»»

Category: blogSource: 247wallstSep 30th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen some bounce in the running week, with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) up about 1.3 percent through Thursday. read more.....»»

Category: blogSource: benzingaSep 24th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen.....»»

Category: earningsSource: benzingaSep 24th, 2018

The Week Ahead In Biotech (Sept. 23-29): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen some bounce in the running week, with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) up about 1.3 percent through Thursday. read more.....»»

Category: blogSource: benzingaSep 23rd, 2018

The Week Ahead In Biotech (Sept. 23-29): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, .....»»

Category: earningsSource: benzingaSep 23rd, 2018

U.S. IPO Week Ahead: 13 IPOs Close Out 3rd Quarter With Biotechs, China And SurveyMonkey

U.S. IPO Week Ahead: 13 IPOs Close Out 3rd Quarter With Biotechs, China And SurveyMonkey.....»»

Category: topSource: seekingalphaSep 22nd, 2018

Tilray stock rises 29% on plans to import cannabis to U.S. for clinical trial

The U.S. Drug Enforcement Administration has signed off on cannabis cultivator Tilray Inc.’s plan to import a pot product from Canada to test a pot pill’s effectiveness at treating a disorder that affects millions of Americans......»»

Category: topSource: marketwatchSep 18th, 2018